Phenethyl phenylacetate | CAS#102-20-5 | Aromachemical

MedKoo Cat#: 592019 | Name: Phenethyl phenylacetate

Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Phenethyl phenylacetate is a highly desirable aromachemical which has not been found to be genotoxic. .

Chemical Structure

Phenethyl phenylacetate

CAS#102-20-5

Theoretical Analysis

MedKoo Cat#: 592019

Name: Phenethyl phenylacetate

CAS#: 102-20-5

Chemical Formula: C16H16O2

Exact Mass: 240.1150

Molecular Weight: 240.30

Elemental Analysis: C, 79.97; H, 6.71; O, 13.32

Price and Availability

Size	Price	Availability	Quantity
1kg	USD 450.00

Bulk Inquiry

Buy Now

Add to Cart

Related CAS #

No Data

Synonym

Phenethyl phenylacetate; AI3-20106; AI3 20106; AI320106

IUPAC/Chemical Name

Acetic acid, phenyl-, phenethyl ester

InChi Key

ZOZIRNMDEZKZHM-UHFFFAOYSA-N

InChi Code

InChI=1S/C16H16O2/c17-16(13-15-9-5-2-6-10-15)18-12-11-14-7-3-1-4-8-14/h1-10H,11-13H2

SMILES Code

O=C(OCCC1=CC=CC=C1)CC2=CC=CC=C2

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.03.00

More Info

Product Data

Product Data

Instruction

View handling instruction

Biological target:

Phenethyl phenylacetate is a biochemical.

In vitro activity:

TBD

In vivo activity:

TBD

Preparing Stock Solutions

The following data is based on the product molecular weight 240.30 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

Formulation protocol:

TBD

In vitro protocol:

TBD

In vivo protocol:

TBD

1: Wu Y, Kang Y, Zhang L, Qu D, Cheng X, Feng L. Performance and fouling mechanism of direct contact membrane distillation (DCMD) treating fermentation wastewater with high organic concentrations. J Environ Sci (China). 2018 Mar;65:253-261. doi: 10.1016/j.jes.2017.01.015. Epub 2017 Mar 8. PubMed PMID: 29548396. 2: Zhang L, Liu Q, Pan H, Li X, Guo D. Metabolic engineering of Escherichia coli to high efficient synthesis phenylacetic acid from phenylalanine. AMB Express. 2017 Dec;7(1):105. doi: 10.1186/s13568-017-0407-0. Epub 2017 May 25. PubMed PMID: 28549374; PubMed Central PMCID: PMC5445031. 3: Sustkova-Fiserova M, Jerabek P, Havlickova T, Kacer P, Krsiak M. Ghrelin receptor antagonism of morphine-induced accumbens dopamine release and behavioral stimulation in rats. Psychopharmacology (Berl). 2014 Jul;231(14):2899-908. doi: 10.1007/s00213-014-3466-9. Epub 2014 Feb 15. PubMed PMID: 24531567. 4: Beckmann JS, Siripurapu KB, Nickell JR, Horton DB, Denehy ED, Vartak A, Crooks PA, Dwoskin LP, Bardo MT. The novel pyrrolidine nor-lobelane analog UKCP-110 [cis-2,5-di-(2-phenethyl)-pyrrolidine hydrochloride] inhibits VMAT2 function, methamphetamine-evoked dopamine release, and methamphetamine self-administration in rats. J Pharmacol Exp Ther. 2010 Dec;335(3):841-51. doi: 10.1124/jpet.110.172742. Epub 2010 Aug 30. PubMed PMID: 20805303; PubMed Central PMCID: PMC2993560. 5: Adams TB, Cohen SM, Doull J, Feron VJ, Goodman JI, Marnett LJ, Munro IC, Portoghese PS, Smith RL, Waddell WJ, Wagner BM; Expert Panel of the Flavor and Extract Manufacturers Association. The FEMA GRAS assessment of phenethyl alcohol, aldehyde, acid, and related acetals and esters used as flavor ingredients. Food Chem Toxicol. 2005 Aug;43(8):1179-206. Epub 2005 Jan 26. Review. PubMed PMID: 15950814. 6: Niazi Shahabi H, Bergquist F, Nissbrandt H. An investigation of dopaminergic metabolites in the striatum and in the substantia nigra in vivo utilising radiolabelled L-DOPA and high performance liquid chromatography: a new approach in the search for transmitter metabolites. Neuroscience. 2003;120(2):425-33. PubMed PMID: 12890512. 7: Agradi E, Fico G, Cillo F, Francisci C, Tomè F. Estrogenic activity of phenolic compounds from Nigella damascena evaluated using a recombinant yeast screen. Planta Med. 2001 Aug;67(6):553-5. PubMed PMID: 11509979. 8: Nissbrandt H, Bergquist F, Jonason J, Engberg G. Inhibition of cytochrome P450 2E1 induces an increase in extracellular dopamine in rat substantia nigra: a new metabolic pathway? Synapse. 2001 Jun 15;40(4):294-301. PubMed PMID: 11309845. 9: Lehmann KA, Hunger L, Brandt K, Daub D. [Biotransformation of fentanyl. III. Effect of chronic drug exposure on the distribution, metabolism and excretion in the rat]. Anaesthesist. 1983 Apr;32(4):165-73. German. PubMed PMID: 6881518. 10: Lehmann KA, Weski C, Hunger L, Heinrich C, Daub D. [Biotransformation of fentanyl. II. Acute drug interactions in rats and men (author's transl)]. Anaesthesist. 1982 May;31(5):221-7. German. PubMed PMID: 7103030. 11: Lehmann KA, Möseler G, Daub D. [I. Metabolism by mouse tissue homogenates in vitro (author's transl)]. Anaesthesist. 1981 Sep;30(9):461-6. German. PubMed PMID: 7283112.